Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$2.78 USD
-0.11 (-3.81%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $2.81 +0.03 (1.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CLOV 2.78 -0.11(-3.81%)
Will CLOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
Centene Pulls 2025 Guidance as Marketplace Growth Falters
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
Here's Why MOH Shares Are Attracting Prudent Investors Now
Ensign Enhances Presence With 3 New Acquisitions in 2 States
Other News for CLOV
CLOV Supports Initiative for Unified Healthcare Data Ecosystem
Clover 'supports' White House, CMS' push for simplifying health data access
Novo Nordisk Stock is on Sale- A Cash Flow Giant
Clover Health Investments Corp (CLOV) Announces Key Leadership Appointment at Counterpart ...